Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Testing method could point thousands more cancer patients to lifesaving treatment
Testing method could point thousands more cancer patients to lifesaving treatment
Bacteria subtype linked to growth in up to 50% of human colorectal cancers, researchers report
Bacteria subtype linked to growth in up to 50% of human colorectal cancers, researchers report
A computational model has been created to simulate the biomechanical growth of breast tumours
A computational model has been created to simulate the biomechanical growth of breast tumours
Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer
Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer
Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies
Genetic test identifies patients with triple negative breast cancer who are unlikely to respond to immunotherapies
Circulating tumor DNA levels predict treatment outcomes for patients with gastroesophageal cancer treated with a novel immunotherapy combination
Circulating tumor DNA levels predict treatment outcomes for patients with gastroesophageal cancer treated with a...
New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status
New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status
Cell therapy approach harnesses the immune system in a different way to stop cancer
Cell therapy approach harnesses the immune system in a different way to stop cancer
Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer
Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer
Olaparib and durvalumab demonstrated strong clinical benefit in mismatch repair proficient advanced or recurrent endometrial cancer
Olaparib and durvalumab demonstrated strong clinical benefit in mismatch repair proficient advanced or recurrent...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation